Detalles de la búsqueda
1.
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Am J Hum Genet
; 99(4): 903-911, 2016 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27640304
2.
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.
Am J Hum Genet
; 97(1): 22-34, 2015 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073781
3.
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
Acta Oncol
; 57(1): 38-43, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29172851
4.
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Breast Cancer Res
; 19(1): 44, 2017 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28356166
5.
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Breast Cancer Res
; 17: 18, 2015 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25849327
6.
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
BMC Cancer
; 15: 978, 2015 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26674097
7.
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Carcinogenesis
; 35(1): 76-85, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24104550
8.
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
Acta Oncol
; 53(10): 1337-46, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24957550
9.
Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size.
J Med Genet
; 50(10): 666-73, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23825393
10.
Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes.
BMC Genomics
; 13: 199, 2012 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22616941
11.
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers.
Sci Rep
; 10(1): 1277, 2020 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992741
12.
AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer.
iScience
; 23(11): 101649, 2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33103086
13.
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 10(1): 525, 2019 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30692535
14.
Breast cancer quantitative proteome and proteogenomic landscape.
Nat Commun
; 10(1): 1600, 2019 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962452
15.
Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.
Mol Oncol
; 12(9): 1540-1558, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741811
16.
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 9(1): 5397, 2018 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559362
17.
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Genome Med
; 10(1): 92, 2018 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30497530
18.
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Nat Commun
; 9: 16193, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633761
19.
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 8(1): 1221, 2017 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089486
20.
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.
Clin Cancer Res
; 23(16): 4662-4670, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28487444